Mozobil



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 39.1%
Haematopoietic Stem Cell Mobilisation 15.8%
Acute Myeloid Leukaemia 14.3%
Drug Use For Unknown Indication 4.4%
Prophylaxis 3.7%
Myelodysplastic Syndrome 2.9%
Multiple Myeloma 2.6%
Bone Marrow Conditioning Regimen 2.2%
Hypertension 1.9%
Nausea 1.9%
Pain 1.8%
Acute Lymphocytic Leukaemia 1.5%
Chronic Lymphocytic Leukaemia 1.3%
Non-hodgkin's Lymphoma 1.2%
Infection Prophylaxis 1.0%
Premedication 1.0%
Prophylaxis Of Nausea And Vomiting 0.9%
Lymphoma 0.9%
Acute Myeloid Leukaemia Recurrent 0.8%
Antifungal Prophylaxis 0.8%
Thrombocytopenia 10.3%
Sepsis 8.7%
Death 6.5%
Febrile Neutropenia 6.5%
Pyrexia 6.5%
Nausea 6.0%
Acute Myeloid Leukaemia 4.9%
Vomiting 4.9%
Deep Vein Thrombosis 4.3%
White Blood Cell Count Decreased 4.3%
Hypersensitivity 3.8%
Infection 3.8%
Interstitial Lung Disease 3.8%
Metastases To Central Nervous System 3.8%
Myocardial Infarction 3.8%
Pancytopenia 3.8%
Plasmacytoma 3.8%
Therapeutic Response Decreased 3.8%
Diarrhoea 3.3%
Neutropenia 3.3%
Secondary
Product Used For Unknown Indication 32.9%
Acute Myeloid Leukaemia 13.4%
Haematopoietic Stem Cell Mobilisation 11.6%
Drug Use For Unknown Indication 5.7%
Infection Prophylaxis 5.0%
Prophylaxis 4.9%
Premedication 4.0%
Multiple Myeloma 3.1%
Mineral Supplementation 2.3%
Dry Eye 2.2%
Bone Marrow Conditioning Regimen 2.1%
Nausea 2.1%
Myelodysplastic Syndrome 1.8%
Diarrhoea 1.6%
Hypertension 1.3%
Prophylaxis Against Graft Versus Host Disease 1.3%
Pain 1.2%
Constipation 1.2%
Gastrooesophageal Reflux Disease 1.2%
Non-hodgkin's Lymphoma 1.1%
Hyperbilirubinaemia 17.1%
Urinary Tract Infection Enterococcal 11.4%
Nausea 7.0%
Therapeutic Response Decreased 6.3%
Influenza 5.1%
Pyrexia 5.1%
Sepsis 5.1%
Thrombocytopenia 5.1%
Acute Myeloid Leukaemia 4.4%
Neutropenia 4.4%
Pneumothorax 3.8%
Diarrhoea 3.2%
Pancytopenia 3.2%
Pneumonia 3.2%
Septic Shock 3.2%
Blood Stem Cell Harvest Failure 2.5%
Cellulitis 2.5%
Infection 2.5%
Respiratory Failure 2.5%
Upper Respiratory Tract Infection 2.5%
Concomitant
Product Used For Unknown Indication 35.1%
Drug Use For Unknown Indication 28.6%
Acute Myeloid Leukaemia 7.1%
Diffuse Large B-cell Lymphoma 6.0%
Haematopoietic Stem Cell Mobilisation 5.4%
Bone Marrow Conditioning Regimen 2.4%
Chronic Myeloid Leukaemia 2.4%
Chemotherapy 2.1%
Antifungal Treatment 1.2%
Mineral Supplementation 1.2%
Plasma Cell Myeloma 1.2%
Premedication 1.2%
Stem Cell Transplant 1.2%
Stomatitis 1.2%
Pain 0.9%
Affective Disorder 0.6%
Antiviral Treatment 0.6%
Anxiety 0.6%
Blood Pressure Abnormal 0.6%
Central Venous Catheterisation 0.6%
Venoocclusive Disease 24.0%
Thrombocytopenia 16.0%
Drug Ineffective 8.0%
Acute Graft Versus Host Disease 4.0%
Blood Immunoglobulin A Increased 4.0%
Diarrhoea 4.0%
Dizziness Postural 4.0%
Escherichia Sepsis 4.0%
Pallor 4.0%
Plasma Cell Myeloma 4.0%
Proctitis 4.0%
Renal Failure 4.0%
Renal Failure Acute 4.0%
Stem Cell Transplant 4.0%
Ventricular Tachycardia 4.0%
Viral Haemorrhagic Cystitis 4.0%